EMMPRIN regulates tumor growth and metastasis by recruiting bone marrow-derived cells through paracrine signaling of SDF-1 and VEGF

Yanke Chen; Xingchun Gou; Derek Kai Kong; Xiaofei Wang; Jianhui Wang; Zeming Chen; Chen Huang; Jiangbing Zhou

doi:10.18632/oncotarget.5331

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

EMMPRIN regulates tumor growth and metastasis by recruiting bone marrow-derived cells through paracrine signaling of SDF-1 and VEGF

Yanke Chen _, Xingchun Gou, Derek Kai Kong, Xiaofei Wang, Jianhui Wang, Zeming Chen, Chen Huang and Jiangbing Zhou

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:32575-32585. https://doi.org/10.18632/oncotarget.5331

Metrics: PDF 2275 views | HTML 2119 views | ?

Abstract

Yanke Chen1,2, Xingchun Gou2,3, Derek Kai Kong2, Xiaofei Wang1, Jianhui Wang4, Zeming Chen2, Chen Huang1, Jiangbing Zhou2,5

1Experiment Center of Biomedical Research School of Medicine, Xi’an Jiaotong University, Xi’an 710061, P. R. China

2Department of Neurosurgery, Yale University, New Haven, CT 06511, USA

3Laboratory of Cell Biology and Translational Medicine, Xi’an Medical University, Xi’an 710021, P. R. China

4Department of Pathology, Yale University, New Haven, CT 06511, USA

5Department of Biomedical Engineering, Yale University, New Haven, CT 06510, USA

Correspondence to:

Jiangbing Zhou, e-mail: [email protected]

Chen Huang, e-mail: [email protected]

Keywords: EMMPRIN, bone marrow-derived cells, SDF-1, VEGF, tumor growth and metastasis

Received: May 06, 2015 Accepted: September 11, 2015 Published: September 22, 2015

ABSTRACT

EMMPRIN, a cell adhesion molecule highly expressed in a variety of tumors, is associated with poor prognosis in cancer patients. Mechanistically, EMMPRIN has been characterized to contribute to tumor development and progression by controlling the expression of MMPs and VEGF. In the present study, by using fluorescently labeled bone marrow-derived cells (BMDCs), we found that the down-regulation of EMMPRIN expression in cancer cells reduces tumor growth and metastasis, and is associated with the reduced recruitment of BMDCs. Further protein profiling studies suggest that EMMPRIN controls BMDC recruitment through regulating the secretion of soluble factors, notably, VEGF and SDF-1. We demonstrate that the expression and secretion of SDF-1 in tumor cells are regulated by EMMPRIN. This study reveals a novel mechanism by which EMMPRIN promotes tumor growth and metastasis by recruitment of BMDCs through controlling secretion and paracrine signaling of SDF-1 and VEGF.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5331

Publication Alerts

Research Papers:

EMMPRIN regulates tumor growth and metastasis by recruiting bone marrow-derived cells through paracrine signaling of SDF-1 and VEGF

Abstract